Moleculin Biotech Future Growth
Future criteria checks 0/6
Moleculin Biotech is forecast to grow earnings and revenue by 43.9% and 79.1% per annum respectively while EPS is expected to grow by 48.2% per annum.
Key information
43.9%
Earnings growth rate
48.2%
EPS growth rate
| Biotechs earnings growth | 42.4% |
| Revenue growth rate | 79.1% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 15 Jun 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | N/A | -35 | -40 | -40 | 3 |
| 12/31/2025 | N/A | -31 | -35 | -34 | 3 |
| 12/31/2024 | N/A | -26 | -28 | -28 | 3 |
| 3/31/2024 | N/A | -27 | -25 | -25 | N/A |
| 12/31/2023 | N/A | -30 | -24 | -24 | N/A |
| 9/30/2023 | N/A | -26 | -26 | -26 | N/A |
| 6/30/2023 | N/A | -29 | -26 | -26 | N/A |
| 3/31/2023 | N/A | -30 | -29 | -29 | N/A |
| 12/31/2022 | N/A | -29 | -28 | -28 | N/A |
| 9/30/2022 | N/A | -25 | -25 | -25 | N/A |
| 6/30/2022 | N/A | -21 | -21 | -21 | N/A |
| 3/31/2022 | N/A | -18 | -20 | -20 | N/A |
| 12/31/2021 | N/A | -16 | -19 | -19 | N/A |
| 9/30/2021 | N/A | -16 | -18 | -18 | N/A |
| 6/30/2021 | N/A | -15 | -19 | -19 | N/A |
| 3/31/2021 | N/A | -21 | -17 | -17 | N/A |
| 12/31/2020 | N/A | -17 | -18 | -18 | N/A |
| 9/30/2020 | N/A | -19 | -20 | -19 | N/A |
| 6/30/2020 | N/A | -19 | -17 | -17 | N/A |
| 3/31/2020 | N/A | -10 | -18 | -18 | N/A |
| 12/31/2019 | N/A | -13 | -17 | -17 | N/A |
| 9/30/2019 | N/A | -12 | -16 | -16 | N/A |
| 6/30/2019 | N/A | -10 | -16 | -15 | N/A |
| 3/31/2019 | N/A | -14 | -14 | -13 | N/A |
| 12/31/2018 | N/A | -12 | -13 | -12 | N/A |
| 9/30/2018 | N/A | -12 | -12 | -11 | N/A |
| 6/30/2018 | N/A | -13 | -10 | -10 | N/A |
| 3/31/2018 | N/A | -11 | -9 | -9 | N/A |
| 12/31/2017 | N/A | -10 | N/A | -7 | N/A |
| 9/30/2017 | N/A | -8 | N/A | -6 | N/A |
| 6/30/2017 | N/A | -7 | N/A | -5 | N/A |
| 3/31/2017 | N/A | -4 | N/A | -5 | N/A |
| 12/31/2016 | N/A | -4 | N/A | -4 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: MOL is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: MOL is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: MOL is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: MOL is forecast to have no revenue next year.
High Growth Revenue: MOL is forecast to have no revenue next year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if MOL's Return on Equity is forecast to be high in 3 years time